Agomab
agomab.comLocations
Antwerp, Belgium · Flanders, Belgium
industry
Biotechnology
Size
51-200 employees
Stage
Series C+
founded in
2017
Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure, and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease-modifying potential in severe organ failure and fibrotic diseases.
Something looks off?Open jobs at Agomab
On-site & Remote
Seniority
Salary